Source:http://linkedlifedata.com/resource/pubmed/id/12780875
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2003-6-3
|
pubmed:abstractText |
Monotherapy is often inadequate and combination drug regimens have become the norm for the treatment of bipolar disorder. Virtually all classes of psychotropic drugs have been used in bipolar disorder in combination for a variety of indications. This article reviews the available published data from controlled, blinded studies regarding combination treatments in the different treatment phases of bipolar disorder.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1398-5647
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
217-25
|
pubmed:dateRevised |
2007-3-22
|
pubmed:meshHeading | |
pubmed:year |
2003
|
pubmed:articleTitle |
Combination treatment in bipolar disorder: a review of controlled trials.
|
pubmed:affiliation |
The Mood and Anxiety Disorders Program, National Institute of Mental Health, Bethesda, MD 20892, USA. zaratec@intra.nimh.nih.gov
|
pubmed:publicationType |
Journal Article,
Review
|